August 10, 2018 MIPS: Invitation to the presentation of the results for the period January – June 2018
August 08, 2018 Strongbridge Biopharma plc Announces Positive Top-Line Results from the Pivotal Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome
August 08, 2018 Strongbridge Biopharma plc Reports Second Quarter 2018 Financial Results and Provides Corporate Update
August 08, 2018 Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2018 Results Presentation and Webcast
July 26, 2018 CERENIS ANNOUNCES FINANCING FROM INVESTMENT FUNDS, MANAGEMENT, ITS BOARD OF DIRECTORS AND ITS ONCOLOGY SCIENTIFIC ADVISORY BOARD